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25-Hydroxy vitamin D (25(OH)D) deficiency is linked with predisposition to autoimmune type 1 diabetes and multiple sclerosis. Our objective was
to assess the relationship between serum 25(OH)D levels and thyroid autoimmunity. Subjects included students, teachers and staff aged
16–60 years (total 642, 244 males, 398 females). Serum free thyroxine, thyroid-stimulating hormone (TSH), and thyroid peroxidase autoantibodies
(TPOAb), intact parathyroid hormone and 25(OH)D were measured by electrochemiluminescence and RIA, respectively. Thyroid dysfunction was
defined if (1) serum TSH $ 5mU/ml and TPOAb . 34 IU/ml or (2) TSH $ 10mU/ml but normal TPOAb. The mean serum 25(OH)D of the study
subjects was 17·5 (SD 10·2) nmol/l with 87% having values #25 nmol/l. TPOAb positivity was observed in 21% of subjects. The relationship
between 25(OH)D and TPOAb was assessed with and without controlling for age and showed significant inverse correlation (r 20·08,
P¼0·04) when adjusted for age. The prevalence of TPOAb and thyroid dysfunction were comparable between subjects stratified according to
serum 25(OH)D into two groups either at cut-off of #25 or .25 nmol/l or first and second tertiles. Serum 25(OH)D values show only weak
inverse correlation with TPOAb titres. The presence of such weak association and narrow range of serum 25(OH)D did not allow us to interpret
the present results in terms of quantitative cut-off values of serum 25(OH)D. Further studies in vitamin D-sufficient populations with wider range
of serum 25(OH)D levels are required to substantiate the findings of the current study.
25-Hydroxy vitamin D: Vitamin D deficiency: Thyroid autoimmunity
Until recently, vitamin D deficiency was considered to be rare
in India because of abundant sunshine(1,2). However, a sys-
tematic study carried out in the year 2000 in Delhi showed
the presence of low 25-hydroxy vitamin D (25(OH)D) in a
majority of subjects including newborns, their mothers,
healthy physicians, nurses, soldiers and those with vitiligo
and albinism. Based on these study groups, subnormal
serum 25(OH)D levels of Asian Indians could be linked to
their skin pigmentation and poor sunshine exposure(1,3). Sub-
sequently, a series of studies have documented widespread
hypovitaminosis D in north as well as south India(3–5).
Besides bone mineral homeostasis, 25(OH)D deficiency has
been associated with a wide range of non-skeletal effects
including predisposition towards autoimmune disorders(6–8).
The demonstration of vitamin D receptor in monocytes,
dendritic cells and activated T cells indicates significant inter-
action between vitamin D and the immune system(6,7). While
the molecular mechanisms linking vitamin D with autoimmu-
nity are under investigation, in vitro studies indicate
an immunomodulatory effect of 1,25(OH)D on Th1, Th2, T
regulator and dendritic cells leading to a shift towards acti-
vation of Th2 cells(6,7). Clinical relevance of the mechanism
is indicated by a number of studies showing increased preva-
lence of autoimmune disease such as multiple sclerosis
in Canada and the northern part of the USA receiving less sun-
shine. Vitamin D supplementation resulted in decreased preva-
lence of autoimmune disorders such as type 1 diabetes and
multiple sclerosis. A recent meta-analysis showed 29%
reduction in the risk of type 1 diabetes in children receiving
vitamin D supplementation(9,10). Similarly, in multiple scler-
osis every 50 nmol/l increase in serum 25(OH)D levels in a
healthy Caucasian population reduced the risk of disease
by 41%(11).
Recent studies using thyroid microsomal or thyroid peroxi-
dase autoantibodies (TPOAb) have revealed a high prevalence
of thyroid autoimmunity in the general population in
India(12,13). Autoimmune hypothyroidism has been estimated
to be the most frequent endocrine autoimmune disorder and
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possibly affects approximately 42 million people in India(14).
Currently, the prevalence of thyroid autoimmunity in children
is as high as 9–13%(12). To the best of our knowledge, there is
no study which has assessed the relationship between
25(OH)D deficiency and thyroid autoimmunity. The current
study has been carried out to assess the relationship, if any,
between thyroid autoimmunity and serum 25(OH)D levels in
Asian Indians.
Material and methods
The study was carried out in four schools and a medical
college of Delhi in November 2006 to March 2007, corre-
sponding to winter months in India. These educational insti-
tutions were selected based on convenience including
availability of consent from the authorities to carry out the
studies among students, teachers and non-teaching staff, and
their proximity to the institutions of the participating investi-
gators. Consent was also obtained from study participants
and parents of school children. The school and colleges
selected were fee-paying and most of the study subjects
belonged to the middle-income group. A day prior to the
survey, school visits were made and subjects were instructed
to report fasting the next day. Subjects ,16 years of age, or
on drugs affecting bone mineral metabolism such as calcium,
vitamin D, glucocorticoids, antitubercular and antiepileptics
were excluded from the present study. A total of 642 subjects
were recruited ((244 males and 398 females; mean age 33·7
(SD 13·5) years (range 15–60 years)). Fasting blood samples
were drawn for the estimation of serum 25(OH)D, intact para-
thyroid hormone (iPTH), total calcium, inorganic phosphorus,
alkaline phosphatase, serum free thyroxine, thyroid-stimulat-
ing hormone (TSH) and TPOAb. Blood was transported in
chilled containers to the All India Institute of Medical
Sciences for hormone and TPOAb estimation.
Assays
Biochemical estimations were carried out using an automated
analyser (Hitachi 902; Roche, Mannheim, Germany) and
commercial kits (Roche). The normal range for serum total
calcium, inorganic phosphorus, alkaline phosphatase and
total magnesium were 2·0–2·6mmol/l, 0·8–1·45mmol/l,
98–279 IU/l and 0·65–0·90mmol/l, respectively. Intra-assay
and inter-assay CV for these assays ranged between 3·5 and
5·0%. Serum 25(OH)D was measured using RIA (Diasorin,
Stillwater, MN, USA). Serum samples for the measurement
of free thyroxine, TSH, TPOAb and iPTH were stored at
2208C and assayed together in multiple batches by an Elecsys
immunoassay kit autoanalyser (Elecsys-2010; Roche). The
normal ranges for serum free thyroxine, TSH, TPOAb and
iPTH were 12–22 pmol/l, 0·27–4·2mU/ml, .34·0 IU/ml and
1·6–6·9 pmol/l, respectively. Inter- and intra-assay CV for
these measurements were 2·9, 8·6, 6·3 and 1·6% and 6·6,
8·7, 9·5 and 3·9%, respectively). The Institutional ethics
committee approved the study protocol and written informed
consent was obtained from all the study subjects. The consent
for the study and the final recruitment varied between 85 and
90% in the study subjects from different schools and the
medical college.
Definitions
Hypovitaminosis D. For the purpose of the current study,
significant hypovitaminosis D was defined as serum
25(OH)D levels #25·0 nmol/l. This value was based on
scatterplot and linear regression analysis between serum
25(OH)D and iPTH as reported in our earlier study(15).
Scatterplot showed a steep and curvilinear relationship
between parathyroid hormone (PTH) and 25(OH)D in the
first (12·2 nmol/l) and second tertile (#25·0 nmol/l). Linear
regression analysis also showed a significant rise in PTH at
the 25(OH)D level of 10–14 nmol/l(15).
Thyroid autoimmunity. TPOAb positivity and thyroid
dysfunction were defined as described earlier(13,16). These
definitions were based on the isolated or composite criteria
currently used to define thyroid autoimmunity and thyroid
dysfunction by the American Association of Clinical
Endocrinologists, the American Thyroid Association and the
Endocrine Society(16,17).
Thyroid peroxidase autoantibody positivity. Serum
TPOAb titres .34 IU/ml were considered positive (Roche).
To assess high-titre TPOAb positivity, an arbitrary cut-off of
103 IU/ml (three times above the normal) was also used.
Thyroid dysfunction. Subjects were considered to have
clinically relevant thyroid dysfunction if they had (1) serum
TSH of at least 5mU/ml along with TPOAb .34 IU/ml or
(2) TSH of at least 10mU/ml but normal TPOAb titres.
Statistical analysis
The data are given as means and standard deviations. Statisti-
cal analysis was performed with SPSS statistical software
version 10.0 (SPSS Inc., Chicago, IL, USA). Student’s t test
and x2 test with Yates correction was used to assess the sig-
nificance of differences in the quantitative and frequency
data. P,0·05 was considered significant.
Results
Table 1 gives the baseline characteristics of study subjects
including their mean age, BMI, serum total calcium, inorganic
phosphorus, alkaline phosphatase, 25(OH)D, iPTH and
TPOAb positivity as well as sex-related differences in these
parameters.
Prevalence of 25-hydroxy vitamin D deficiency
The mean serum 25(OH)D value of study subjects was 17·5
(SD 10·2) nmol/l; 87% (95% CI 84·5, 89·6) of subjects had
25(OH)D #25 nmol/l. There was no significant difference in
the frequency of hypovitaminosis D between males and
females (85·2 and 88·2%, respectively, P¼0·169). Though
females had significantly higher BMI, there was no significant
correlation between serum 25(OH)D and BMI or body weight
in the whole group (r 0·022 and 0·020, respectively, P.0·5 for
both) as well as in females (r 0·063 and 0·049, respectively,
P.0·5 for both).
The mean serum total magnesium value was normal and
only three (0·5%) individuals had serum total magnesium
in the subnormal range. There was an inverse relationship
between 25(OH)D and PTH (r 20·184, P,0·001).
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The r value between these two parameters remained the same
even after controlling for serum total magnesium on partial
correlation analysis. Biochemical hyperparathyroidism, indi-
cated by serum iPTH .6·9 pmol/l, was present in 28·5% of
subjects and its frequency was not significantly different
between males and females (28·3 and 28·6%, respectively,
P¼0·498). The frequency of biochemical hyperparathyroidism
was significantly higher in those with serum level
#25·0 nmol/l as compared to those with levels .25 nmol/l
(31·1 and 10·8%, respectively, P,0·001).
Prevalence of thyroid autoimmunity
TPOAb positivity was found in 21% (95% CI 17·7, 24·0) of
subjects. Eighty-four (62·7%) of the subjects had TPOAb
titres .103 IU/ml. The frequency of TPOAb positivity (cut-
off 34 IU/ml, 23·6 and 16·4%, P¼0·035) and those with
TPOAb titres .103 IU/ml (15·6 and 9·0%, P¼0·01) were
higher in females as compared to the males. Interestingly,
there was a significant positive relationship between serum
TPOAb titres and age in the present study population
(r 0·170, P,0·001). Thyroid dysfunction was present in
100/642 (15·65%) subjects. Eighty-four of these had TPOAb
.34·0 IU and TSH .5mU/ml (13·1%, males 9·0% and
females 15·6%, P¼0·01) and 16 (2·5%) had only TSH
levels .10·0mU/ml with no TPOAb positivity (males 1·6%
and females 3·0%, P¼0·20).
Inter-relationship between 25-hydroxy vitamin D deficiency
and thyroid peroxidase autoantibody positivity
The correlation coefficient between TPOAb and 25(OH)D
(r 20·044, P¼0·268) and between serum TPOAb titres and
PTH (r 0·064, P¼0·107) were not significant. In view of the
fact that serum TPOAb significantly correlated with age, the
relationship between 25(OH)D and TPOAb was also assessed
using partial correlation analysis after controlling for age. The
results showed significant inverse correlation between the two
parameters (r 20·08, P¼0·04).
Serum 25-hydroxy vitamin D and its relation to parameters
of thyroid autoimmunity. The prevalence of thyroid autoim-
munity at cut-off of 34·0 and 103 IU/ml, the mean TPOAb
titres and frequency of thyroid dysfunction between groups
with serum 25(OH)D #25·0 and .25·0 nmol/l are shown in
Table 2. Though, the two groups stratified on the basis of
25(OH)D cut-off had significantly different mean 25(OH)D
and iPTH levels, none of the parameters related to prevalence
of thyroid autoimmunity including frequency of thyroid
dysfunction were significantly different in the two groups. The
differences in the parameters related to thyroid autoimmunity
Table 2. Thyroid autoimmunity in relation to serum 25-hydroxy vitamin D (25(OH)D) levels*
(Mean values and standard deviations)
25(OH)D levels
#25·0 nmol/l
(n 559)
.25·0 nmol/l
(n 83)
Parameters Mean SD Mean SD OR 95 % CI P
Serum PTH (pmol/l) 6·3 4·0 4·8 1·8 ,0·001
Serum 25(OH)D (nmol/l) 14·5 3·5 37·5 16·3 ,0·001
TPOAb (.34 IU) (%) 21·3 18·1 1·23 0·65, 2·33 0·56
Mean TPOAb titres (IU/ml)† 58·0 4·9 45·8 10·4 0·36
TPOAb titres .103 IU/ml (%) 13·2 12·0 1·1 0·53, 2·41 0·86
Thyroid dysfunction
TPOAb .34 IU/ml and TSH .5 IU/ml (%) 13·2 12·0 1·1 0·53, 2·41 0·86
TSH .10mU/ml and TPOAb ,34 IU/ml (%) 2·5 2·4 1·04 0·22, 6·75 0·74
25(OH)D, 25-hydroxy vitamin D; PTH, parathyroid hormone; TPOAb, thyroid peroxidase autoantibodies; TSH, thyroid-stimulating hormone.
* For details of procedures and subjects, see the Material and methods section and Table 1.
† Data shown as means and standard errors of the mean because of high standard deviations of the data.
Table 1. Characteristics of the study subjects and sex-specific differences
All subjects Males Females
Parameters Mean SD Mean SD Mean SD P value between males and females
n 642 244 398
Mean age (years) 33·7 13·5 31·4 13·4 35·1 13·4 ,0·01
BMI (kg/m2) 24·9 9·0 23·6 4·2 25·3 5·0 ,0·01
Serum total calcium (mmol/l) 2·50 0·16 2·54 0·16 2·47 0·15 ,0·01
Serum inorganic phosphorus (mmol/l) 1·19 0·20 1·21 0·21 1·18 0·19 0·12
Serum alkaline phosphatase (IU/l) 241 113 285 122 215 70 ,0·01
Serum 25(OH)D (nmol/l) 17·5 10·2 18·0 9·1 17·2 10·9 0·31
iPTH (pmol/l) 6·10 3·27 6·03 2·84 6·15 3·51 0·65
TPOAb positivity (%)* 20·9 16·4 23·6 0·04
iPTH, intact parathyroid hormone; 25(OH)D, 25-hydroxy vitamin D; TPOAb, thyroid peroxidase autoantibodies.
* TPOAb titres .34·0 IU/ml.
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were also looked after the study subjects were stratified into
tertiles according to their serum 25(OH)D levels. Although
the mean serum 25(OH)D values between subjects in the
first and third tertiles were significantly different (12·23
(SD 0·2) and 27·0 (SD 13·4) nmol/l), prevalence of TPOAb
positivity either at a cut-off of 34·0 (22·3% v. 19·0%) or at
103 IU/ml (14·4% v. 11·8%) was comparable in these tertiles.
Similarly, prevalence of thyroid dysfunction (TSH .10·0mU/
ml and TPOAb negative; 2·7% v. 3·3% and TSH .5·0 but
TPOAb positive; 14·4% v. 11·8%) was comparable between
the subjects in the first and third tertiles.
Thyroid autoimmunity and its relation to 25-hydroxy
vitamin D status. The mean serum 25(OH)D, iPTH and fre-
quencyof subjects showing biochemical hyperparathyroidism
(iPTH .6·9 pmol/l) were not significantly different in serum
TPOAb-positive and -negative individuals (17·4 (SD 12·3) and
17·5 (SD 9·6) nmol/l; 6·2 (SD 3·4) and 6·1 (SD 3·2) pmol/l; 28·4
and 28·5%, respectively). Similarly all the above parameters
were not significantly different between groups with TPOAb
titres #103 or .103 IU/ml.
Discussion
The observation that the mean 25(OH)D levels were as low as
17·5 (SD 10·2) nmol/l and that 85% of study participants had
levels #25 nmol/l, confirms our earlier reports of wide preva-
lence of hypovitaminosis D in apparently healthy Asian
Indians(1–5). Though the present study was carried out in the
winter months when the serum 25(OH)D values are expected
to be low, one of our previous studies showed that the mean
serum 25(OH)D values were far below the optimum level
(17·9 (SD 7·9) nmol/l) in Asian Indians even during the
summer months(1). The findings of the current study showing
hypovitaminosis D in a large number of Asian Indians assume
further importance in view of the fact that deficiency was
observed in subjects recruited from teaching institutions
despite nearly a decade of awareness about the presence and
the contributory factors of vitamin D deficiency in Delhi(1).
Recently, we have also observed the absence of any change
in vitamin D receptor expression levels in subjects with hypo-
vitaminosis D(10). These facts indicate lack of bio-adaptation
of vitamin D receptor levels in man and a need for continued
efforts to highlight the wide prevalence of hypovitaminosis
even in countries with an abundance of sunshine and a vitamin
D fortification programme(18).
In our previous studies, we have documented the functional
significance of vitamin D deficiency in Asian Indians in terms
of its association with a rise in serum PTH levels(1,11),
decreased bone mineral content(5) and poor dietary calcium
absorption from the intestine. Recently, 25(OH)D deficiency
has also been associated with a wide range of non-skeletal dis-
orders including malignancies, coronary artery disease and
autoimmune disorders such as type 1 diabetes and multiple
sclerosis(9). A recent meta-analysis showed a 29% reduction
in the risk of type 1 diabetes in children receiving vitamin
D supplementation(12,13). Similarly, in multiple sclerosis
every 50 nmol/l increase in serum 25(OH)D levels in a healthy
Caucasian population reduced the risk of disease by 41%(14).
Though autoimmune thyroid disorders are more prevalent
than type 1 diabetes and multiple sclerosis, there has been
no study assessing association between thyroid autoimmunity
and 25(OH)D status. The high prevalence of TPOAb and
thyroid dysfunction observed in the current study involving
a large cohort of the population is similar to that reported
in healthy Indians of a similar age group(7). The presence
of TPOAb positivity in up to 21% of the general population
in India and thyroid dysfunction in up to 15% of them
could possibly be related to the successful salt iodisation pro-
gramme which has been ongoing in India since 1992.
Similar high prevalence of TPOAb and thyroid dysfunction
has also been reported in a population-based survey from
an iodine-sufficient region of Western Australia(16). Walsh
et al., while studying the relationship of thyroid autoimmunity
with parity observed 26% prevalence of TPOAb positivity
or TSH elevation in 1045 women from the general popu-
lation(16).
The presence of a high prevalence of thyroid autoimmu-
nity and vitamin D deficiency in the Indian population pro-
vided us with a unique opportunity to assess association
between these two variables. The results of the current
study indicate the presence of a significant inverse associ-
ation between 25(OH)D levels and thyroid autoimmunity
as reflected in TPOAb titres. Though the relationship
assumed statistical significance, the R 2 value was only
0·006, indicating that only 0·6% variation in thyroid autoim-
munity was determined by 25(OH)D levels in the present
study population. The presence of such a weak association
and narrow range of serum 25(OH)D values did not allow
us to interpret the present results in terms of quantitative
cut-off values of serum 25(OH)D either in groups with
serum 25(OH)D .25 nmol/l or in those with serum
25(OH)D values in the third tertile. The narrow range of
serum 25(OH)D observed in our population could have led
to us missing the possible protective effect of higher
levels of serum 25(OH)D on thyroid autoimmunity. Further
studies in vitamin D-sufficient populations with a wider
range of serum 25(OH)D levels are required to substantiate
the findings of the current study.
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